{
  "metadata": {
    "version": "1.0.0",
    "last_updated": "08-09-2025",
    "reference_genome": "GRCh38/hg38",
    "sources": ["ClinVar", "OMIM", "dbSNP", "gnomAD", "1000Genomes", "MedlinePlus", "PubMed"],
    "database_description": "Comprehensive HBB gene pathogenic variants and protective modifiers for sickle cell disease risk assessment"
  },
  
  "pathogenic_variants": {
    "rs334": {
      "name": "HbS - Sickle Cell Variant",
      "gene": "HBB",
      "chromosome": 11,
      "position": 5227002,
      "ref": "T",
      "alt": "A",
      "hgvs_c": "c.20A>T",
      "hgvs_p": "p.Glu6Val",
      "amino_acid_change": "β6 Glu→Val",
      "clinical_significance": "pathogenic",
      "clinvar_id": "VCV000015333.166",
      "omim_id": "603903",
      "disease": "sickle_cell_disease",
      "severity_score": 10,
      "inheritance_pattern": "autosomal_recessive",
      "mechanism": "hemoglobin_polymerisation",
      "frequency": {
        "african_american": 0.043,
        "west_african": 0.15,
        "east_african": 0.15,
        "european": 0.001,
        "global": 0.01
      },
      "clinical_impact": {
        "homozygous": {
          "phenotype": "severe_sickle_cell_disease",
          "severity": "severe",
          "complications": ["vaso_occlusive_crises", "acute_chest_syndrome", "stroke"]
        },
        "heterozygous": {
          "phenotype": "sickle_cell_trait",
          "severity": "asymptomatic",
          "benefit": "malaria_protection"
        },
        "compound_het_with_beta_thal": {
          "phenotype": "sickle_beta_thalassemia",
          "severity": "moderate_to_severe"
        }
      }
    },
    
    "rs33930165": {
      "name": "HbC Variant",
      "gene": "HBB",
      "chromosome": 11,
      "position": 5226980,
      "ref": "G",
      "alt": "A",
      "hgvs_p": "p.Glu6Lys",
      "amino_acid_change": "β6 Glu→Lys",
      "clinical_significance": "pathogenic",
      "disease": "hemoglobin_c_disease",
      "severity_score": 6,
      "inheritance_pattern": "autosomal_recessive",
      "frequency": {
        "african": 0.0034,
        "west_african": 0.02,
        "global": 0.0005
      },
      "clinical_impact": {
        "homozygous": {
          "phenotype": "hbc_disease",
          "severity": "mild",
          "complications": ["mild_anemia", "splenomegaly"]
        },
        "heterozygous": {
          "phenotype": "hbc_trait",
          "severity": "asymptomatic"
        },
        "compound_het_with_hbs": {
          "phenotype": "hbsc_disease",
          "severity": "moderate"
        }
      }
    },
    
    "rs33950507": {
      "name": "HbE Variant",
      "gene": "HBB",
      "chromosome": 11,
      "position": 5226918,
      "ref": "G",
      "alt": "A",
      "hgvs_p": "p.Glu26Lys",
      "amino_acid_change": "β26 Glu→Lys",
      "clinical_significance": "pathogenic",
      "disease": "hemoglobin_e_disease",
      "severity_score": 5,
      "inheritance_pattern": "autosomal_recessive",
      "frequency": {
        "southeast_asian": 0.0028,
        "thai": 0.43,
        "global": 0.02
      },
      "clinical_impact": {
        "homozygous": {
          "phenotype": "hbe_disease",
          "severity": "mild",
          "complications": ["mild_thalassemia_phenotype"]
        },
        "heterozygous": {
          "phenotype": "hbe_trait",
          "severity": "asymptomatic"
        },
        "compound_het_with_beta_thal": {
          "phenotype": "hbe_beta_thalassemia",
          "severity": "severe"
        }
      }
    },
    
    "rs33946267": {
      "name": "HbD Punjab/Los Angeles",
      "gene": "HBB",
      "chromosome": 11,
      "position": 5226820,
      "ref": "G",
      "alt": "C",
      "hgvs_p": "p.Glu121Gln",
      "amino_acid_change": "β121 Glu→Gln",
      "clinical_significance": "pathogenic",
      "disease": "hemoglobin_d_disease",
      "severity_score": 4,
      "inheritance_pattern": "autosomal_recessive",
      "frequency": {
        "punjabi": 0.02,
        "northern_indian": 0.01,
        "global": 0.0001
      },
      "clinical_impact": {
        "homozygous": {
          "phenotype": "hbd_disease",
          "severity": "mild",
          "complications": ["mild_hemolytic_anemia"]
        },
        "heterozygous": {
          "phenotype": "hbd_trait",
          "severity": "asymptomatic"
        }
      }
    },
    
    "ivs1_1": {
      "name": "IVS1-1 G>A Splice Donor",
      "gene": "HBB",
      "chromosome": 11,
      "position": 5226937,
      "ref": "G",
      "alt": "A",
      "hgvs_c": "c.92+1G>A",
      "molecular_change": "splice_donor_mutation",
      "clinical_significance": "pathogenic",
      "disease": "beta_zero_thalassemia",
      "severity_score": 9,
      "thalassemia_type": "beta_zero",
      "beta_globin_production": 0,
      "frequency": {
        "mediterranean": 0.02,
        "italian": 0.03,
        "global": 0.001
      },
      "clinical_impact": {
        "homozygous": {
          "phenotype": "thalassemia_major",
          "severity": "severe",
          "treatment": "transfusion_dependent"
        },
        "heterozygous": {
          "phenotype": "thalassemia_minor",
          "severity": "mild"
        },
        "compound_het_with_hbs": {
          "phenotype": "severe_sickle_beta_thal",
          "severity": "severe"
        }
      }
    },
    
    "rs11549407": {
      "name": "Codon 39 Nonsense",
      "gene": "HBB",
      "chromosome": 11,
      "position": 5226970,
      "ref": "C",
      "alt": "T",
      "hgvs_c": "c.118C>T",
      "hgvs_p": "p.Gln39*",
      "amino_acid_change": "nonsense_mutation",
      "clinical_significance": "pathogenic",
      "disease": "beta_zero_thalassemia",
      "severity_score": 9,
      "thalassemia_type": "beta_zero",
      "beta_globin_production": 0,
      "frequency": {
        "sardinian": 0.954,
        "mediterranean": 0.05,
        "global": 0.0005
      },
      "clinical_impact": {
        "homozygous": {
          "phenotype": "thalassemia_major",
          "severity": "severe",
          "treatment": "transfusion_dependent"
        },
        "heterozygous": {
          "phenotype": "thalassemia_minor",
          "severity": "mild"
        }
      }
    },
    
    "ivs1_110": {
      "name": "IVS1-110 G>A Cryptic Splice",
      "gene": "HBB",
      "chromosome": 11,
      "position": 5226845,
      "ref": "G",
      "alt": "A",
      "hgvs_c": "c.93-21G>A",
      "molecular_change": "cryptic_splice_acceptor",
      "clinical_significance": "pathogenic",
      "disease": "beta_plus_thalassemia",
      "severity_score": 7,
      "thalassemia_type": "beta_plus",
      "beta_globin_production": 0.15,
      "mechanism": "creates_aberrant_splice_acceptor_19bp_upstream",
      "frequency": {
        "turkish": 0.45,
        "mediterranean": 0.08,
        "global": 0.001
      },
      "clinical_impact": {
        "homozygous": {
          "phenotype": "thalassemia_intermedia",
          "severity": "moderate"
        },
        "heterozygous": {
          "phenotype": "thalassemia_minor",
          "severity": "mild"
        }
      }
    }
  },
  
  "modifier_variants": {
    "BCL11A": {
      "rs1427407": {
        "name": "BCL11A Major HbF Inducer",
        "chromosome": 2,
        "position": 60718043,
        "region": "BCL11A_erythroid_specific_enhancer",
        "ref": "G",
        "alt": "T",
        "effect": "increased_HbF",
        "modifier_score": -3,
        "mechanism": "disrupts_BCL11A_enhancer",
        "hbf_variance_explained": 0.23,
        "hbf_increase": 0.15,
        "frequency": {
          "african": 0.24,
          "european": 0.10,
          "global": 0.15
        },
        "clinical_benefit": "reduced_scd_severity"
      },
      
      "rs4671393": {
        "name": "BCL11A Strongest HbF Association",
        "chromosome": 2,
        "position": 60716189,
        "region": "BCL11A_intron_2",
        "ref": "G",
        "alt": "A",
        "effect": "increased_HbF",
        "modifier_score": -4,
        "mechanism": "BCL11A_expression_reduction",
        "statistical_significance": "2e-42",
        "hbf_variance_explained": 0.181,
        "hbf_increase": 0.20,
        "frequency": {
          "african": 0.18,
          "european": 0.08,
          "global": 0.12
        },
        "clinical_benefit": "improved_survival"
      },
      
      "rs11886868": {
        "name": "BCL11A Intronic Modifier",
        "chromosome": 2,
        "position": 60718023,
        "region": "BCL11A_intron_2",
        "ref": "T",
        "alt": "C",
        "effect": "increased_HbF",
        "modifier_score": -2,
        "mechanism": "BCL11A_regulatory_variant",
        "hbf_variance_explained": 0.14,
        "hbf_increase": 0.10,
        "frequency": {
          "african": 0.39,
          "european": 0.20,
          "global": 0.25
        },
        "clinical_benefit": "mild_amelioration"
      }
    },
    
    "HBS1L_MYB": {
      "rs9399137": {
        "name": "HMIP-2 Tag SNP",
        "chromosome": 6,
        "position": 135419018,
        "region": "HBS1L_MYB_intergenic_HMIP2_block",
        "ref": "T",
        "alt": "C",
        "effect": "increased_HbF",
        "modifier_score": -3,
        "mechanism": "MYB_enhancer_regulation",
        "f_cell_variance_explained": 0.176,
        "hbf_increase": 0.12,
        "frequency": {
          "african": 0.15,
          "european": 0.22,
          "global": 0.18
        },
        "clinical_benefit": "reduced_sickling_crises"
      },
      
      "rs4895441": {
        "name": "HBS1L-MYB Modifier",
        "chromosome": 6,
        "position": 135426177,
        "region": "HBS1L_intron",
        "effect": "increased_HbF",
        "modifier_score": -2,
        "mechanism": "intergenic_regulatory",
        "hbf_increase": 0.08,
        "frequency": {
          "african": 0.20,
          "european": 0.25,
          "global": 0.22
        },
        "clinical_benefit": "reduced_vaso_occlusive_crises",
        "population_validation": "confirmed_across_ethnic_groups"
      }
    }
  },
  
  "novel_variants_2020_2025": {
    "saudi_arabian": [
      {
        "name": "c.252C>T",
        "hgvs_c": "c.252C>T",
        "type": "exonic",
        "clinical_significance": "pathogenic"
      },
      {
        "name": "c.281G>T",
        "hgvs_c": "c.281G>T",
        "type": "exonic",
        "clinical_significance": "pathogenic"
      },
      {
        "name": "c.316-183_316-168del",
        "hgvs_c": "c.316-183_316-168del",
        "type": "intronic_deletion",
        "clinical_significance": "pathogenic"
      }
    ],
    "turkish_syrian": [
      {
        "name": "c.31_32insT",
        "hgvs_c": "c.31_32insT",
        "type": "frameshift",
        "population": "syrian",
        "clinical_significance": "pathogenic"
      }
    ],
    "pakistani": [
      {
        "name": "c.375A>C",
        "hgvs_c": "c.375A>C",
        "hgvs_p": "p.P125P",
        "type": "synonymous_affects_splicing",
        "clinical_significance": "pathogenic"
      },
      {
        "name": "c.*61T>G",
        "hgvs_c": "c.*61T>G",
        "type": "3_utr_variant",
        "mechanism": "affects_stability",
        "clinical_significance": "pathogenic"
      }
    ]
  },
  
  "haplotypes": {
    "bantu": {
      "name": "Bantu",
      "severity": "severe",
      "hbf_baseline": 0.05,
      "geographic_origin": "central_africa",
      "marker_snps": ["rs3834466", "rs28440105"],
      "clinical_features": "severe_vaso_occlusive_crises",
      "severity_rank": 1
    },
    "benin": {
      "name": "Benin",
      "severity": "intermediate",
      "hbf_baseline": 0.08,
      "geographic_origin": "west_africa",
      "marker_snps": ["rs968857", "rs10128556"],
      "clinical_features": "moderate_disease_course",
      "severity_rank": 2
    },
    "senegal": {
      "name": "Senegal",
      "severity": "mild",
      "hbf_baseline": 0.12,
      "geographic_origin": "atlantic_west_africa",
      "marker_snps": ["rs7482144"],
      "clinical_features": "higher_hbf_better_prognosis",
      "severity_rank": 3
    },
    "arab_indian": {
      "name": "Arab-Indian",
      "severity": "mild",
      "hbf_baseline": 0.15,
      "geographic_origin": "arabian_peninsula_india",
      "marker_snps": ["rs10837631"],
      "clinical_features": "mildest_scd_phenotype",
      "severity_rank": 4
    }
  },
  
  "scoring_algorithm": {
    "weights": {
      "primary_mutation": 0.60,
      "bcl11a_modifiers": 0.20,
      "hbs1l_myb_modifiers": 0.10,
      "other_modifiers": 0.10
    },
    "normalisation_factor": 5,
    "max_score": 100
  },
  
  "severity_categories": {
    "minimal_risk": {
      "score_range": [0, 20],
      "description": "No sickle cell disease",
      "management": "No intervention needed",
      "monitoring": "Standard care"
    },
    "carrier_status": {
      "score_range": [20, 40],
      "description": "Sickle cell trait or thalassemia minor",
      "management": "Genetic counseling recommended",
      "monitoring": "Annual check-up"
    },
    "moderate_risk": {
      "score_range": [40, 70],
      "description": "Mild to moderate sickle cell disease",
      "management": "Regular monitoring, consider hydroxyurea",
      "monitoring": "Quarterly visits"
    },
    "high_risk": {
      "score_range": [70, 100],
      "description": "Severe sickle cell disease",
      "management": "Aggressive treatment, consider gene therapy",
      "monitoring": "Monthly visits, comprehensive care"
    }
  },
  
  "clinical_thresholds": {
    "protective_hbf_level": 0.15,
    "therapeutic_hbf_target": 0.30,
    "survival_benefit_hbf": 0.086,
    "transfusion_dependency_score": 80,
    "hydroxyurea_consideration": 50,
    "gene_therapy_eligibility": 70,
    "hydroxyurea_response_predictors": ["rs1427407", "rs4671393"]
  },
  
  "genotype_severity_hierarchy": [
    {
      "rank": 1,
      "genotype": "HbSS",
      "description": "Homozygous sickle cell disease",
      "severity": "most_severe"
    },
    {
      "rank": 1,
      "genotype": "HbS/β⁰-thalassemia",
      "description": "Sickle beta-zero thalassemia",
      "severity": "most_severe"
    },
    {
      "rank": 2,
      "genotype": "HbS/β⁺-thalassemia",
      "description": "Sickle beta-plus thalassemia",
      "severity": "intermediate"
    },
    {
      "rank": 3,
      "genotype": "HbSC",
      "description": "Hemoglobin SC disease",
      "severity": "variable_mild_to_moderate"
    }
  ],
  
  "population_considerations": {
    "african": {
      "rs334_frequency": 0.043,
      "regional_variation": {
        "west_africa": "10-19%",
        "east_africa": "10-20%",
        "southern_africa": "<2%"
      },
      "haplotype_diversity": ["bantu", "benin", "senegal", "cameroon"]
    },
    "mediterranean": {
      "beta_thalassemia_predominance": true,
      "common_variants": ["codon_39", "ivs1_110", "ivs1_1", "ivs1_5_6"],
      "founder_effects": "strong_regional_clustering"
    },
    "asian": {
      "hbe_prevalence": "up_to_43_percent_southeast_asia",
      "beta_thalassemia_variants": "population_specific",
      "modifier_frequencies": "lower_hbs1l_myb_variants"
    }
  },
  
  "clinical_implementation": {
    "genetic_testing_strategy": {
      "primary_screening": ["HPLC", "IEF", "complete_blood_count"],
      "confirmatory_testing": "NGS_based_HBB_analysis",
      "modifier_analysis": ["BCL11A_variants", "HBS1L_MYB_variants"]
    },
    "risk_assessment_steps": [
      "primary_genotype_determination",
      "hbf_modifier_scoring",
      "population_specific_adjustment",
      "clinical_severity_prediction"
    ],
    "therapeutic_implications": {
      "gene_therapy_eligible": ["HbSS", "HbS/β⁰-thal"],
      "hydroxyurea_enhanced_response": ["rs1427407", "rs4671393"],
      "family_planning": "carrier_screening_risk_assessment"
    }
  }
}